• SENSEX 78,553.20
    1,508.91 (+1.96%)
  • BANKNIFTY 53,117.75
    738.25 (+1.41%)
  • Avenue Super.
    4,395.00 5,484.00(%)
  • Infosys
    1,429.40 2,006.80(%)
  • Waaree Renewab.
    1,170.00 3,037.75(%)
  • Mazagon Dock
    2,695.15 1,046.00(%)
  • ICICI Bank
    1,408.60 1,372.50(%)
  • HDFC Bank
    1,919.35 1,882.05(%)
  • Nip. India Nifty
    266.74 292.58(%)
  • Tata Motors
    626.90 1,179.05(%)
  • KFin Technolog.
    1,145.00 1,640.00(%)
  • Coforge
    6,668.00 10,017.95(%)
  • Angel One
    2,385.85 3,502.60(%)
  • Wipro
    232.20 208.40(%)
  • Glenmark Pharma.
    1,336.95 985.60(%)
  • St Bk of India
    801.00 912.10(%)
  • IndusInd Bank
    800.85 1,550.00(%)
  • SpiceJet
    51.29 79.90(%)
  • Bharti Airtel
    1,897.95 1,826.75(%)
  • Suzlon Energy
    55.71 86.04(%)
  • Reliance Industr
    1,279.45 1,608.95(%)
  • NBCC
    100.00 139.83(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

SMS Lifesciences India Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 68575.0
  • ISIN : INE320X01016
1,269.90 136 (12.01%)
  • As on 17 Apr 2025 (EOD)

  • Today’s Low

    1,144.10

  • Today’s High

    1,295.00

  • Open

    1,170.80

  • Perv Close

    1,133.70

  • 52W Low

    626.45

  • 52W High

    1,749.65

Key Indicators

  • P/E(TTM)

    15.62

  • Mar.Cap (₹Cr.)

    383.93

  • Div & Yield %

    0.12

  • Book Value(₹)

    621.86

  • Debt-Equity Ratio

    12.01

  • AGM Date

    16-Apr-2025

  • EPS

    81.46

  • P/E Ratio

    15.62

Financials Ratios

  • Debt-Equity Ratio

    0.58

  • Mar.Cap (₹Cr.)

    383.93

  • RONW (%)

    3.67

  • ROCE (%)

    7.24

Score Board

  • Equity (₹ in Cr.)

    3.02

  • BV (₹)

    621.90

  • Sales( ₹ in Cr.)

    300.00

  • NP (in Cr.)

    11.79

  • NP Var(%)

    4.0

  • Div%

    15.0

  • CPS (₹)

    72.90

  • EPS (₹)

    39.00

  • Traded Value (₹ in Lakhs)

    384.70

  • 52 Week High

    1,749.65

  • 52 Week Low

    626.45

  • Price BSE

    1272.0

  • Price NSE

    1,270.00

  • Market Capital( in Cr.)

    384.70

  • P/C Ratio

    17.40

  • P/E Ratio

    32.60

  • Price Vs.BV

    39.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 328.75 351.88 379.12 286.88 282.61 375.69
Excise Duty 28.75 36.63 33.49 26.63 25.68 31.53
Net Sales 300.00 315.25 345.63 260.25 256.93 344.16
Other Income 3.84 5.23 14.23 1.33 1.88 2.53
Stock Adjustments -0.98 -0.30 7.79 -1.90 -6.29 8.19
Total Income 302.86 320.18 367.65 259.68 252.52 354.88
EXPENDITURE :            
Raw Materials 161.19 189.95 216.16 137.76 155.75 238.47
Power and Fuel Cost 26.46 25.66 26.32 19.52 18.73 24.11
Employee Cost 37.94 34.72 32.51 27.11 23.27 20.63
Other Manufacturing Expenses 24.19 24.08 32.06 27.22 18.91 23.73
Selling and Administration Expenses 12.60 11.69 13.20 11.94 8.99 11.50
Miscellaneous Expenses 2.10 2.36 1.74 5.01 1.17 1.43
Employee Benefit Expenses 37.94 34.72 32.51 27.11 23.27 20.63
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 264.49 288.46 321.99 228.55 226.83 319.87
Operating Profit 38.38 31.71 45.65 31.14 25.68 34.99
Interest 9.01 5.16 4.68 4.57 5.10 5.46
Gross Profit 29.37 26.55 40.97 26.57 20.58 29.53
Depreciation 10.25 8.17 7.99 7.21 7.24 5.77
Profit Before Tax 19.12 18.38 32.98 19.36 13.34 23.76
Current Tax 4.05 3.15 7.56 5.03 3.30 6.29
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.99 2.01 0.04 1.16 0.89 0.83
Reported Net Profit 13.07 13.22 25.38 13.17 9.15 16.63
Extraordinary Items 1.27 1.87 9.47 0.01 0.06 -0.06
Adjusted Net Profit 11.80 11.35 15.91 13.16 9.09 16.69
Adjustment below Net Profit -0.41 0.05 -0.05 -0.09 -0.42 -0.06
P & L Balance brought forward 90.83 80.02 57.14 45.06 36.79 20.21
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 2.45 2.45 2.45 1.00 0.45 0.00
P & L Balance carried down 101.03 90.83 80.02 57.14 45.06 36.79
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 15.00 15.00 15.00 15.00 0.00 15.00
Dividend Per Share(Rs) 1.50 1.50 1.50 1.50 0.00 1.50
Earnings Per Share-Unit Curr 43.22 43.72 83.95 43.56 30.26 55.02
Earnings Per Share(Adj)-Unit Curr 43.22 43.72 83.95 43.56 30.26 55.02
Book Value 582.90 542.55 500.16 417.88 374.61 347.23
Book Value(Adj)-Unit Curr 582.90 542.55 500.16 417.88 374.61 347.23

Shareholding Pattern

  • Promoter Group

    71.41%

  • Public Share Holding

    28.59%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 8,000 0.26 8,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,150,789 71.14 2,150,789 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,158,789 71.41 2,158,789 12
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 83,971 2.78 83,919 56
Clearing Members 194 0.01 194 5
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 7,714 0.26 7,678 127
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 105,006 3.47 105,006 4
Individuals holding nominal share capital up to Rs. 1 lakh 667,525 22.08 659,627 7,271
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 61 0.00 0 1
Others 10 0.00 10 2
Sub Total 864,498 28.59 856,451 7,467
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 3,023,287 100.00 3,015,240 7,479

Company Background

SMS Lifesciences India LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • SMS Lifesciences India Ltd
  • BSE Code : 68575.0
  • ISIN : INE320X01016

  • Incorporation Year

    2006

  • Registered Office

    Plot No 19-III Road No 71
    Opp Bharatiya Vidya Bhavan PSc, Hyderabad,
    Telangana-500096

  • Telephone

    91-040-6628-8888

  • FAX

    91-040-2355-1401

  • Chairman

  • Managing Director

    T V V S N Murthy

  • Company Secretary

    Trupti Ranjan Mohanty

  • Auditor

    Rambabu & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Aarthi Consultants Pvt Ltd
    1-2-285 Domalguda,
    ,
    Mumbai - Hyderabad - 500 029

SMS Lifesciences India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
SMS Lifesciences 1,272.45 303.84 328.75 15.62 10.68
Abbott India 30,715.80 6,097.18 5,848.91 48.91 44.71
Astrazeneca Phar 8,511.00 1,330.33 1,295.53 219.41 33.26
P & G Health Ltd 5,223.15 1,166.89 1,151.26 36.65 39.76
Glaxosmi. Pharma 2,928.60 3,530.73 3,407.25 58.23 44.44
Cipla 1,496.50 17,645.00 16,574.34 25.66 20.10
Amrutanjan Healt 683.10 437.58 421.23 40.04 20.84
Guj. Themis Bio. 292.25 174.19 169.82 60.51 44.82
Fermenta Biotec. 275.00 315.24 307.09 26.07 4.10
Bliss GVS Pharma 123.15 638.96 605.46 28.18 11.19
Ambalal Sarabhai 38.88 11.70 3.81 16.62 1.92